Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trinity Biotech (TRIBY) -- Ignore unavailable to you. Want to Upgrade?

To: J.F. who wrote (8050)	2/10/1998 11:32:00 AM
From: Roger Bodine	Read Replies (2) \| Respond to of 14328

Anyone...Is there any reason to hold this stock. It never goes anywhere. I bought 2000 because of the company products but the stock sits right in the same place forever. Would like to keep it longer but where is the motivation. Please share any good reasons. Thanks, Roger

To: J.F. who wrote (8050)	2/10/1998 11:54:00 AM
From: Keiko	Respond to of 14328

J.F., Excellent post ! This is why this thread continues to so very informative, everyone is willing to contribute the latest news breaks. Frost & Sullivan is an excellent Bookmark.. frost.com As you all know many patients on "blood thinners " require very close monitoring and those tests ( Prothrombin times & PTT ) are quite expensive and require frequent visits to a Clinical lab. A hand held Coagulation monitor that may be used in the home is the answer . A couple other diseases which were not mentioned by F & S are anemia and polycythemia ( excessive buildup of Red Blood Cells ) ... Wampole has just recently announced their Hct/ Hb analyzer. It is a hand held device that monitors an anemic patients Hemaglobin and Hematocrit ( packed cell volume) ..http://www.wampolelabs.com Just yesterday Cell Robotics...(CRII ) had news on their Lasette non-invasive blood lancet....Just imagine the market this presents for all the pediatric patients that now do finger stiks ?..OUCH ! biz.yahoo.com As the CEO of Trinity mentioned in his last Conference Call they are going after these POCT markets which are the fastest growing segment of laboratory medicine. &&&......yikes....DOW up over 100 !....Dublin ? are you with us.